Bookmark and Share

Publications - Other Parasites

Lee MG, Atkinson BL, Giannini SH, Van der Ploeg LH. Structure and expression of the hsp 70 gene family of Leishmania major. Nucleic Acids Res. 1988;16:9567-85.

Beltz LA, Kierszenbaum F and Sztein MB. Trypanosoma cruzi-induced suppression of human peripheral blood lymphocytes activated via the alternative (CD2) pathway. Infect. Immun. 1990;58:1114-1116.

Giannini SH, Curry SS, Tesh RB, Van der Ploeg LH. Size-conserved chromosomes and stability of molecular karyotype in cloned stocks of Leishmania major. Mol. Biochem. Parasitol. 1990;39:9-21.

Kierszenbaum F, Cuna WR, Beltz LA and Sztein MB. Trypanosomal immunosuppressive factor (TIF): a secretion product(s) of Trypanosoma cruzi that inhibits proliferation and IL-2 receptor expression by activated human peripheral blood mononuclear cells. J. Immunol. 1990;144:4000-4004.

Kierszenbaum F and Sztein MB. Mechanisms underlying immunosuppression induced by Trypanosoma cruzi. Parasitol. Today 1990;6:261-264.

Nord J, Ma P, DiJohn D, Tzipori S, Tacket CO. Treatment of cryptosporidial diarrhea in AIDS patients with bovine hyperimmune colostrum. AIDS 1990;4:581-584.

Saravia NG, Weigle K, Segura I, Giannini SH, Pacheco R, Labrada LA, Goncalves A. Recurrent lesions in human Leishmania braziliensis infection--reactivation or reinfection? Lancet. 1990;336:398-402.

Sztein MB, Cuna W, Beltz LA and Kierszenbaum F. Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8 and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes. J. Immunol. 1990;144:3558-3562.

Sztein MB, Kierszenbaum F. Trypanosoma cruzi suppresses the ability of activated human lymphocytes to enter the cell cycle. J. Parasitol. 1991;77:502-505.

Sztein MB, Kierszenbaum F. A soluble factor from Trypanosoma brucei rhodesiense that prevents progression of activated human T lymphocytes through the cell cycle. Immunology 1991;73:180-185.

Kierszenbaum F, Muthukkumar S, Beltz LA, Sztein MB. Suppression by Trypanosoma brucei rhodesiense of the capacities of human T lymphocytes to express interleukin-2 receptors and proliferate after mitogenic stimulation. Infect. Immun. 1991;59:3518-3522.

Kierszenbaum F, Moretti E, Sztein MB. Trypanosoma cruzi induces suppression of DNA synthesis and inhibits expression of interleukin-2 receptors by stimulated human B lymphocytes. Immunology 1991;74:317-392.

Kierszenbaum F. and Sztein M. Trypanosoma cruzi suppresses the expression of the p75 chain of interleukin-2 receptors on the surface of activated helper and cytotoxic human lymphocytes. Immunology 75: 546-549, 1992.

Sztein M. and Kierszenbaum F. Suppression by Trypanosoma cruzi of t cell receptor expression by activated human lymphocytes. Immunology 77: 277-283, 1992.

Kierszenbaum, F., Moretti, E. and Sztein, M.B. Molecular Basis of Trypanosoma cruzi-induced Immunosuppression. Altered Expression by activated lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle. Biological Res. 26: 197-207, 1993.

Mejia Lopez, H., Tanner, M.K., Kierszenbaum, F. and Sztein, M.B. Alterations Induced by Trypanosoma cruzi in Activated Mouse Lymphocytes. Parasite Immunol. 77: 273-280, 1993.

Sztein, M.B. and Kierszenbaum, F. Mechanisms of Development of Immunosuppression During Trypanosoma Infections. Parasitol. Today 9: 424-428, 1993.

Kierszenbaum, F., Mejia Lopez, H. and Sztein, M.B. Does Interleukin-2 Restore Lymphocyte Responses Suppressed by Trypanosoma cruzi ?. Immunology. 80: 445-450, 1993.

Davis JR, Wasserman SL, Trpis M. Diurnal periodicity of Simulium yahense biting activity and onchocerciasis transmission. Journal of Medical Entomology, 1994, 31(2): 217-224.

Kierszenbaum, F., Mejia Lopez, H. and Sztein, M.B. Inhibition of Trypanosoma cruzi-specific Immune Responses by a Protein Produced by T. cruzi in the Course of Chagas' Disease. Immunology. 81: 462-467, 1994.

Kierszenbaum F, Lopez HM, Sztein MB. Trypanosoma cruzi downregulates the production of interleukin-2, interferon-gamma, interleukin-4 and interleukin-5 by activated human lymphocytes. J. Parasitol. 1996;82:652-656.

Gonzalez CR, Noriega FR, Huerta S, Santiago A, Vega M, Paniagua J, Ortiz-Navarrete V, Isibasi A, Levine MM. Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana. Vaccine 1998;May-16(9-10):1043-52.

Edelman R, Palmer K, Russ KG, Secrest HP, Becker JA, Bodison SA, Perry JG, Sills AR, Barbour AG, Luke CJ, Hanson MS, Stover CK, Burlein JE, Bansal GP, Connor EM, Koenig S. Safety and immunogenicity of recombinant Bacille Calmette-Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine. Vaccine. 1999;17:904-14.

Kierszenbaum F, Majumder S, Paredes P, Tanner MK, Sztein MB. The Trypanosoma cruzi immunosuppressive factor (TIF) targets a lymphocyte activation event subsequent to increased intracellular calcium ion concentration and translocation of protein kinase C but previous to cyclin D2 and cdk4 mRNA accumulation. Mol. Biochem. Parasitol. 1998;92:133-45.

Kierszenbaum F, de Diego JL, Fresno M, Sztein MB. Inhibitory effects of the Trypanosoma cruzi membrane glycoprotein AGC10 on the expression of IL-2 receptor chains and secretion of cytokines by subpopulations of activated human T lymphocytes. Eur. J. Immunol. 1999;29:1684-91.

Newman RD, Sears CL, Moore SR, Nataro JP, Wuhib T, Agnew DA, Guerrant RL, Lima AA. Longitudinal study of Cryptosporidium infection in children in northeastern Brazil. J. Infect. Dis. 1999;180:167-75.